Today's Top Science Story

International Space Station crew has enough supplies for at least six months: Russian official

MOSCOW (Reuters) - The crew aboard the International Space Station (ISS) has enough fuel, oxygen, water, and food to last at least six months, Vladimir Solovyov, flight director of the Russian segment of the ISS, was cited as saying by Russian news agencies on Sunday. Read More


More Science Stories

Russia may resume manned space flights on November 28: Interfax

MOSCOW (Reuters) - The next manned flight of a Soyuz rocket to the International Space Station (ISS) could take place on Nov. 28, Interfax news agency quoted a Russian space industry source on Saturday as saying. More »


Virgin's Branson halts talks on $1 billion Saudi investment in space ventures

(Reuters) - British billionaire Richard Branson said on Thursday that his Virgin Group would suspend its discussions with Saudi Arabia's Public Investment Fund over a planned $1 billion investment in the group's space ventures, in light of the disappearance of Saudi journalist Jamal Khashoggi. More »


Bristol-Myers to invest in Compugen, collaborate in clinical trials

TEL AVIV (Reuters) - Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors. More »


Scientists use stem cells and gene editing to make mice with two mums

LONDON (Reuters) - Chinese scientists said on Thursday they had used gene editing and stem cell techniques to produce healthy mice with two mothers which developed well enough to go on to have normal offspring of their own. More »


Boeing rocket for NASA over budget, could further delay launch: audit

ORLANDO, Fla. (Reuters) - Boeing Co is building the largest rocket in NASA's history but the aerospace giant's "poor performance" has resulted in an $8.9 billion price tag that is double the initial budget and could further delay the launch, the U.S. space agency's watchdog office said on Wednesday. More »


J&J's Stelara succeeds in chronic bowel disease study

(Reuters) - Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. More »


Tech breakthrough offers early warning system for heart attacks

OXFORD, England (Reuters) - A new method of analyzing images from CT scans can predict which patients are at risk of a heart attack years before it occurs, researchers say. More »


Akcea Therapeutics genetic disease treatment gets FDA approval

(Reuters) - Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. More »


Rocket failure astronauts will go back into space - Russian official

MOSCOW (Reuters) - Two astronauts who survived the mid-air failure of a Russian rocket will fly again and are provisionally set to travel to the International Space Station (ISS) in spring of next year, the head of Russia's space agency said on Friday. More »


News, Photo and Web Search